GMP and IMP are competitive inhibitors of CMY-10, an extended-spectrum class C β-lactamase

Jung Hyun Na, Young Jun An, Sun Shin Cha

Research output: Contribution to journalArticlepeer-review

12 Scopus citations

Abstract

Nucleotides were effective in inhibiting the class C β-lactamase CMY-10. IMP was the most potent competitive inhibitor, with a Ki value of 16.2 μM. The crystal structure of CMY-10 complexed with GMP or IMP revealed that nucleotides fit into the R2 subsite of the active site with a unique vertical binding mode where the phosphate group at one terminus is deeply bound in the subsite and the base at the other terminus faces the solvent.

Original languageEnglish
Article numbere00098
JournalAntimicrobial Agents and Chemotherapy
Volume61
Issue number5
DOIs
StatePublished - May 2017

Bibliographical note

Funding Information:
This study was supported by the National Research Foundation of Korea grants (NRF-2015R1A2A2A01004168 and NRF-2015M1A5A1037480) and by a grant from Marine Biotechnology Program (PJT200620) funded by Ministry of Oceans and Fisheries, South Korea

Publisher Copyright:
Copyright © 2017 American Society for Microbiology. All Rights Reserved.

Keywords

  • Competitive inhibitor
  • GMP
  • IMP
  • β-lactamases

Fingerprint

Dive into the research topics of 'GMP and IMP are competitive inhibitors of CMY-10, an extended-spectrum class C β-lactamase'. Together they form a unique fingerprint.

Cite this